Literature DB >> 23152529

Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy.

Martha Stefanidou1, Irene Ramos, Veronica Mas Casullo, Janie B Trépanier, Sara Rosenbaum, Ana Fernandez-Sesma, Betsy C Herold.   

Abstract

Herpes simplex virus 2 (HSV-2) may cause frequent recurrences, highlighting its ability to evade host defense. This study tested the hypothesis that HSV-2 interferes with dendritic cell (DC) function as an escape mechanism, which may contribute to enhanced HIV replication in coinfected populations. Immature monocyte-derived human DCs were exposed to live or UV-inactivated HSV-2 or lipopolysaccharide. Little or no increase in the maturation marker CD83 was observed in response to HSV-2 and HSV-2 exposed DCs were impaired in their ability to present antigen (influenza) to T cells. Exposure to UV-inactivated virus stimulated a modest, but significant increase in CD83, suggesting that viral gene expression contributes to the block in DC maturation. The functional impairment of HSV-2-exposed DCs could be partially attributed to the induction of apoptosis. Live and inactivated HSV-2 triggered an increase in the number of early and late apoptotic cells in both the infected and bystander cell populations; apoptosis was associated with a decrease in cellular FLICE-inhibitory protein (c-FLIP). Paradoxically, HSV-2 induced Akt phosphorylation, which typically promotes DC maturation and survival. Despite these aberrant responses, live and inactivated HSV-2 induced the release of cytokines into culture supernatants, which were sufficient to activate HIV-1 replication in latently infected U1 cells. Together, these findings suggest that in the presence of overt or subclinical HSV-2, the function of mucosal DCs would be impaired. These responses may allow HSV to escape immune surveillance but may also promote HIV infection and contribute to the epidemiological link between HIV and HSV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152529      PMCID: PMC3554174          DOI: 10.1128/JVI.01302-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Synergistic copathogens--HIV-1 and HSV-2.

Authors:  Lawrence Corey
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

Review 2.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

3.  Influenza virus evades innate and adaptive immunity via the NS1 protein.

Authors:  Ana Fernandez-Sesma; Svetlana Marukian; Barbara J Ebersole; Dorothy Kaminski; Man-Seong Park; Tony Yuen; Stuart C Sealfon; Adolfo García-Sastre; Thomas M Moran
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

Authors:  X Wan; B Harkavy; N Shen; P Grohar; L J Helman
Journal:  Oncogene       Date:  2006-09-25       Impact factor: 9.867

5.  Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1.

Authors:  Luca Benetti; Bernard Roizman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies.

Authors:  Nicolas Nagot; Abdoulaye Ouedraogo; Marie-Christine Defer; Roselyne Vallo; Philippe Mayaud; Philippe Van de Perre
Journal:  Sex Transm Infect       Date:  2007-05-10       Impact factor: 3.519

7.  Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells.

Authors:  Adi Reske; Gabriele Pollara; Claude Krummenacher; David R Katz; Benjamin M Chain
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  Murine gammaherpesvirus-68 productively infects immature dendritic cells and blocks maturation.

Authors:  Romana Hochreiter; Catherine Ptaschinski; Steven L Kunkel; Rosemary Rochford
Journal:  J Gen Virol       Date:  2007-07       Impact factor: 3.891

9.  Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.

Authors:  Nicolas Nagot; Abdoulaye Ouédraogo; Vincent Foulongne; Issouf Konaté; Helen A Weiss; Laurence Vergne; Marie-Christine Defer; Didier Djagbaré; Anselme Sanon; Jean-Baptiste Andonaba; Pierre Becquart; Michel Segondy; Roselyne Vallo; Adrien Sawadogo; Philippe Van de Perre; Philippe Mayaud
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

10.  Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial.

Authors:  Abdoulaye Ouedraogo; Nicolas Nagot; Laurence Vergne; Issouf Konate; Helen A Weiss; Marie-Christine Defer; Vincent Foulongne; Anselme Sanon; Jean-Baptiste Andonaba; Michel Segondy; Philippe Mayaud; Philippe Van de Perre
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

View more
  39 in total

1.  The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.

Authors:  Kieran Seay; Nazanin Khajoueinejad; Jian Hua Zheng; Patrick Kiser; Christina Ochsenbauer; John C Kappes; Betsy Herold; Harris Goldstein
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

2.  T cell response kinetics determines neuroinfection outcomes during murine HSV infection.

Authors:  Aisha G Lee; Jason M Scott; Maria Rita Fabbrizi; Xiaoping Jiang; Dorothy K Sojka; Mark J Miller; Megan T Baldridge; Wayne M Yokoyama; Haina Shin
Journal:  JCI Insight       Date:  2020-03-12

3.  Coregulatory interactions among CD8α dendritic cells, the latency-associated transcript, and programmed death 1 contribute to higher levels of herpes simplex virus 1 latency.

Authors:  Kevin R Mott; Sariah J Allen; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  Multiple Functions of Cellular FLIP Are Essential for Replication of Hepatitis B Virus.

Authors:  Ah Ram Lee; Keo-Heun Lim; Eun-Sook Park; Doo Hyun Kim; Yong Kwang Park; Soree Park; Dong-Sik Kim; Gu-Choul Shin; Hong Seok Kang; Juhee Won; Heewoo Sim; Yea Na Ha; Byeongjune Jae; Seong Il Choi; Kyun-Hwan Kim
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

5.  MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.

Authors:  Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

6.  Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women.

Authors:  Laura E Richert-Spuhler; Laura Pattacini; Margot Plews; Elizabeth Irungu; Timothy R Muwonge; Elly Katabira; Nelly Mugo; Adrienne F A Meyers; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

7.  c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.

Authors:  Xuehua Piao; Sachiko Komazawa-Sakon; Takashi Nishina; Masato Koike; Jiang-Hu Piao; Hanno Ehlken; Hidetake Kurihara; Mutsuko Hara; Nico Van Rooijen; Günther Schütz; Masaki Ohmuraya; Yasuo Uchiyama; Hideo Yagita; Ko Okumura; You-Wen He; Hiroyasu Nakano
Journal:  Sci Signal       Date:  2012-12-18       Impact factor: 8.192

8.  Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.

Authors:  Briana Nixon; Martha Stefanidou; Pedro M M Mesquita; Esra Fakioglu; Theodore Segarra; Lisa Rohan; William Halford; Kenneth E Palmer; Betsy C Herold
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 9.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

10.  Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.

Authors:  Tajanna Stinn; Steve Kuntz; Dana Varon; Meei-Li Huang; Stacy Selke; Samuel Njikan; Emily S Ford; Joan Dragavon; Robert W Coombs; Christine Johnston; Marta E Bull
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.